Mono Pharmacare Ltd (MONP)

Currency in INR
24.15
-0.15(-0.62%)
Closed·

MONP Financial Summary

Key Ratios

P/E Ratio14.54
Price/Book1.44
Debt / Equity171.48%
Return on Equity10.46%
Dividend Yield0.00%
EBITDA86.17M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
2025
31/03
* In Millions of INR (except for per share items)

Earnings

Latest Release
May 31, 2025
EPS / Forecast
0.45 / --
Revenue / Forecast
821.18M / --
EPS Revisions
Last 90 days

FAQ

What were Mono Pharmacare's earnings for the latest quarter?

The Mono Pharmacare EPS (TTM) is 1.75. Mono Pharmacare reported sales of 821.18, net income of 7.97, and EPS of 0.45 for the latest quarter.

What was Mono Pharmacare's net income for the latest quarter?

Mono Pharmacare's net income for the latest quarter was 7.97.

How did Mono Pharmacare's performance compare year-over-year in the latest quarter?

The company's revenue moved from 872.06 in the previous quarter to 821.18 in the latest quarter, and net income moved from 22.93 to 7.97 compared to the previous quarter.

What is Mono Pharmacare's net profit margin on a TTM basis?

Mono Pharmacare's trailing twelve months (TTM) net profit margin is 1.83%.

How does Mono Pharmacare's debt to equity ratio compare to industry standards?

Mono Pharmacare's total debt-to-equity ratio is 171.48%.

What is Mono Pharmacare's return on investment on a TTM basis?

Mono Pharmacare's trailing twelve months (TTM) return on investment (ROI) is 10.46%.

Did Mono Pharmacare gain or lose cash last quarter?

In the latest quarter, Mono Pharmacare's net change in cash was 5.67 million.

What were Mono Pharmacare's total assets and liabilities in the latest quarter?

As of the latest quarter, Mono Pharmacare reported total assets of 1,100.55 million and total liabilities of 527.76 million.

How has Mono Pharmacare's total revenue grown this year?

Mono Pharmacare's total revenue was 872.06 in the previous quarter and 821.18 in the latest quarter.

What is Mono Pharmacare's gross margin on a TTM basis?

Mono Pharmacare's trailing twelve months (TTM) gross margin is 10.04%.

What was Mono Pharmacare's revenue per share for the latest quarter?

Mono Pharmacare's revenue per share for the latest quarter was 299.13.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.